LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DiaSys Acquires Intersep

By HospiMedica staff writers
Posted on 17 Oct 2000
DiaSys Corp. (New York, NY, USA) has acquired Intersep Limited, a UK-based manufacturer of consumable laboratory products, reagents, and test kits. DiaSys designs, manufactures, and distributes medical laboratory equipment. Intersep will become a wholly owned subsidiary of DiaSys, which will consolidate all European manufacturing, sales, and service operations under the new subsidiary's managing director, Paul Reardon.

Todd M. DeMatteo, president and CEO of DiaSys, stated that the company acquired Intersep because of the tremendous product and market synergies between the two firms. He said that Intersep's consumable products and reagents are like "blades” for the "razors” of DiaSys. DeMatteo also noted that Intersep has a strong European presence, a network of distributors, and several key European certifications, all of which are indispensable to DiaSys' strategic growth plan.

"DiaSys is a good acquisition partner because it is well-organized and has a very sound strategic growth plan,” said Intersep's Reardon. He stated that the combination of the companies not only furthers the objectives of DiaSys' growth plan but also creates a distribution platform for numerous additional products and system-selling strategies.

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit

Latest Industry News

Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID
17 Oct 2000  |   Industry

QuidelOrtho Adds Ultra-Fast PCR Platform with LEX Acquisition
17 Oct 2000  |   Industry

QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026
17 Oct 2000  |   Industry